NATICK, Massachusetts, July 28, 2010 /PRNewswire-FirstCall/ —
– Company Expands Market-leading Family of Neurovascular
Stents
Boston Scientific Corporation (NYSE: BSX) today announced the U.S. and European
launches of the Neuroform EZ(TM) Stent System, its
fourth-generation intracranial aneurysm stent system designed for
use in conjunction with endovascular coiling to treat wide-necked
aneurysms. The Company plans to launch the product immediately in
both markets.
The Neuroform EZ Stent System is engineered to provide
flexibility and conformability, especially in tortuous brain
anatomy. It employs Boston Scientific’s proprietary Segmental(TM)
Expansion technology, designed to enhance stent anchoring and
stability. The product features the proven hybrid cell design of
prior-generation Neuroform Stents while incorporating a simplified,
single-operator delivery system intended to facilitate preparation,
delivery and positioning of the stent.
The first Neuroform EZ Stent was implanted in the U.S. by Demetrius Lopes, M.D., of the Rush University Medical Center in Chicago, and the first European
procedure was performed by Professor Laurent Spelle, M.D., Ph.D., at Foundation
Rothschild Hospital, Beaujon School of Medicine in Paris.
“The Neuroform EZ Stent System performed well in a very
challenging first procedure,” said Dr. Lopes. “The smooth transfer
of the stent into the catheter, combined with excellent support,
stability and visibility, facili
‘/>”/>
SOURCE